Serina Therapeutics (SER) Return on Assets (2019 - 2026)
Serina Therapeutics (SER) posted Return on Assets of 0.03% for Q4 2025, down 12.39% sequentially from 0.02% in Q3 2025, and little changed YoY from 0.03% in Q4 2024.
Serina Therapeutics (SER) Return on Assets (2019 - 2026) Analysis & Trends
Serina Therapeutics has reported Return on Assets for 7 years, with the latest figure at 0.03% in Q4 2025.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.03% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.03% (changed 0.0% YoY) and the FY2025 annual result came in at 0.03%, down 1.0% from the prior year.
- Return on Assets slipped to 0.03% in Q4 2025 per SER's latest filing, from 0.02% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q4 2021 and troughed at 0.13% in Q2 2023.
- A 5-year average of 0.02% and a median of 0.02% in 2022 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2023 and 2024: Return on Assets declined 11 bps in 2023, then climbed 12 bps in 2024.
- Over 5 years, Return on Assets stood at 0.0% in 2021, then plunged by 9751 bps to 0.04% in 2022, then soared by 92 bps to 0.0% in 2023, then tumbled by 772 bps to 0.03% in 2024, then climbed by 3 bps to 0.03% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 0.03%, 0.02%, and 0.03% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 0.00% |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | -0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Dec 31, 2025 | -0.03% |
| Sep 30, 2025 | -0.02% |
| Jun 30, 2025 | -0.03% |
| Mar 31, 2025 | -0.03% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.13% |
| Mar 31, 2023 | -0.04% |
| Dec 31, 2022 | -0.04% |
| Sep 30, 2022 | -0.03% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |